Trial Details

Not Recruiting
Basic Information
Clinical ID c5057
Identifier EUCTR2022-000875-37-IT
Trial Title A Prospective, Randomized, Placebo-controlled Clinical Trial of oral vancomycin in adults and young adults (15-17 years old) affected by Primary Sclerosing Cholangitis with or without Inflammatory Bowel Disease - Vancomycin in Primary Sclerosing Cholangit
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Primary Sclerosing Cholangitis MedDRA version: 20.1 Level: LLT Classification code 10036732 Term: Primary sclerosing cholangitis. System Organ Class: 100000004871;Therapeutic area: Diseases [C] - Digestive Syste
Interventions Trade Name: LEVOVANOXProduct Name: LEVOVANOXProduct Code: [LEVOVANOX]Pharmaceutical Form: Capsule, hardINN or Proposed INN: VANCOMICINA CLORIDRATOCurrent Sponsor code: VANCOMICINAConcentration unit: mg milligram(s)Concentra
Participant Information
Sponsor UNIVERSIT? DEGLI STUDI MILANO BICOCCA
City NULL
Country/Region Italy
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement NULL
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE2
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL